Pharmaceutical Janssen Biotech from Leiden has asked the American medicines authority for permission to put its corona vaccine on the market.
That announced the American parent company Johnson & Johnson (J&J). This is an application for accelerated vaccine approval with the Food and Drug Administration (FDA).
Janssen reported last week based on trials that their corona vaccine offers 66 percent protection against the coronavirus. That is lower than with other means.
According to tests, the already approved vaccines from Pfizer / BioNTech and from Moderna offer about 90 percent protection.
After FDA approval, delivery of the vaccines can begin immediately, says Johnson & Johnson Scientific Director Paul Stoffels. The United States signed a contract in August to supply 100 million doses of the Janssen vaccine.
The European Union has also agreed to supply 200 million doses of the vaccine once it is proven safe and effective against Covid-19, the disease caused by the coronavirus. More than 11 million of those doses have been ordered by the Netherlands.
Johnson & Johnson expects to apply for a license for the use of the vaccine from the European Medicines Agency EMA in the “coming weeks”.